Feed PROK
PR
ProKidney Corp.
PROK · NASDAQ
$1.69 +3.68% (+$0.06)
1M +1.86%
Market Cap $250.4M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$1.86
10.1% upside
Preț actual
$1.69
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile PROK sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
0 /100
Expensive P/S 379.97x
EV/EBITDA N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 14,636.90%
Op. margin 46,878.00%
FCF margin 21,897.30%
Quality
0 /100
Poor ROA 32.94%
Asset turnover 0.00x
ROIC 82.47%
Debt
43 /100
Moderate Int. coverage -603.19x
Current ratio 9.06x
Net debt/EBITDA N/A
Stability
30 /100
Unstable EPS volatility 38.96%
Profitable years 0
Beta 1.68x
Întreabă StockBot despre PROK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bruce Culleton
Employees
231
Headquarters
Winston-Salem